维普中文期刊产品整合服务
15篇 您的检索式:作者名="Crown I"
    题名 作者 年代 出处 被引量
1Stomatal conductance correlates with photosynthetic capacity 显示文摘WONG S C CROWN I R FARQUHAR G D 1979Nature1979,282,:1
2The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor -positive, HER2 -negative, advanced breast cancer (PALOMA -1/TRIO -18) :a randomised phase 2 study 显示文摘Finn RS Crown JP Lang I 2015Lancet Oncol2015,16,1:1
3The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of estrogen receptor-positive, HER2- negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study显示文摘Finn RS Crown JP Lang I 2015Lancet Oncol2015,16,1:1
4The cyclin - dependenl kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first - line treatment of oestrogen receptor - positive, HER2 - negative, advaneed breast cancer (PALOMA-IrrRIO-18): a randomised phase 2 study显示文摘J FINN RS CROWN JP LANG I 2015Lancet Oncol2015,16,1:1
5The cyclin-dependent kinase 4/ 6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2- negative, advanced breast cancer (PALOMA-1/TRIO-18) : a ran- domised phase 2 study 显示文摘FINN RS CROWN JP LANG I 2015Lancet Oncol2015,16,1:1
6Predicting diatom communities at the genus level for the rapid biological assessment of rivers 显示文摘Chessman B Crown I Currey J Plunkett-cole N 1999Freshwater Biol1999,41,:1
7Stomatal conductance correlates with photosynthetic capacity 显示文摘Wong S C Crown I R Farquhar G D 1979Nature1979,282,5737:1
8The cyclin-dependent ki- nase 4/6 inhibitor palbociclib in combination with letrozole ver- sus letrozole alone as first-line treatment of oestrogen recep- tor-positive, HER2-negative, advanced breast cancer (PALO- MA-1/TRIO-18): a randomised phase 2 study显示文摘Finn R S Crown J P Lang I 2015Lancet On- col2015,16,1:1
9Emerging targeted therapies in triple-negative breast cancer显示文摘Crown J O'Shaughnessy I Gullo G 2012Ann Oncol2012,23,6:1
10The cyclin-dependent kinase 4/6inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative advanced breast cancer (PALOMA-1/TRIO-18): A randomised phase 2 study 显示文摘Finn R S Crown J P Lang I 2015Lancet Oncol2015,16,1:1
11The cyclin-dependent kinase 4/ 6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2- negative, advanced breast cancer (PALOMA-1/TRIO-18) : a ran- domised phase 2 study 显示文摘FINN RS CROWN JP LANG I 2015Lancet Oncol2015,16,1:1
12The cyclin-dependent kinase 4/6 inhibi- tor palbociclib in combination with letrozole versus letrozole alone as fi rst-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer ( PALOMA-1/TRIO-18 ) : a randomised phase 2 study显示文摘Finn RS Crown JP Lang I 2015Lancet Oncol2015,16,1:1
13The cyclin-dependent kinase4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive,HER2-negative,advanced breast cancer(PALOMA-1/TRIO-18):a randomised phase 2 study显示文摘Finn R S Crown J P Lang I 2015The Lancet Oncology2015,16,1:1
14Transcriptional analysis ofthe three Nlrpl paralogs in mice 显示文摘Sastalla I Crown D Masters SL 2013BMC Genomics2013,14,:1
15The cyclin-dependent kinase 4/6 in- hibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer( PALOMA-1/TRIO-18 ) : a randomised phase 2 study 显示文摘Finn RS Crown JP Lang I 2015Lancet Onco12015,16,1:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费